Recombinant human thyrotropin enhances endothelial-mediated vasodilation of conduit arteries

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 3, 2009, Pages 1012-1016

  Napoli, Raffaele ^a,b   Apuzzi, Valentina ^a   Bosso, Giorgio ^a   D'Anna, Carolina ^a   De Sena, Antonietta ^a   Pirozzi, Concetta ^a   Marano, Aldo ^a   Lupoli, Gelsy Arianna ^a   Cudemo, Giuseppe ^a   Oliviero, Ugo ^a   Matarazzo, Margherita ^a   Lupoli, Giovanni ^a   Saccá, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of Internal Medicine and Cardiovascular Sciences ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; INTERLEUKIN 6; RECOMBINANT THYROTROPIN; THYROTROPIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERIAL PRESSURE; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HOLTER MONITORING; HORMONE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; VASODILATATION;

EID: 62349099914     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2298     Document Type: Article

References (24)

1. Klein I, Danzi S 2007 Thyroid disease and the heart. Circulation 116:1725- 1735
2. Drvota V, Janson A, Norman C, Sylvén C, HäggbladJ, Brömiegard M, Marcus C 1995 Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211:426-431
3. Milgrom E, de Roux N, Ghinea N, Beau I, Loosfelt H, Vannier B, Savouret JF, Misrahi M 1997 Gonadotropin and thyrotropin receptors. Horm Res 48: 33-37
4. Sellitti DF, Dennison D, Akamizu T, Doi SQ, Kohn LD, Koshiyama H 2000 Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. Thyroid 10:219-225
5. Donnini D, Ambesi-Impiombato FS, Curcio F 2003 Thyrotropin stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 13:517-521
6. Bastenie PA, Vanhaelst L, Goldstein J, Smets P 1977 Asymptomatic autoimmune thyroiditis and coronary heart disease. Cross-sectional and prospective studies. Lancet 2:155-158
7. Hak AE, Pols HAP, Visser TJ,Drexhage HA, Hoftnan A, Witteman JCM2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132:270-278
8. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444
9. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F 2003 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731-3737
10. Imaizumi M, Akahoshi M, Icliimaru S, Nakashima E, Hida A, SodaM, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K 2004 Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 89:3365-3370
11. Obuobie K, Smith J, Evans LM, John R, Davies JS, Lazarus JH 2002 Increased central arterial stiffness in hypothyroidism. J Clin Endocrinol Metab 87:4662-4666
12. Lekakis J, Papamicliael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA 1997 Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7:411-414
13. Erbil Y, Ozbey N, Girics M, Salmaslioǧlu A, Ozarmaǧan S, Tezelman S 2007 Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. Br J Surg 94:1485-1490
14. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, Taddei S, Ferrannini E, Salvetti A, Monzani F 2006 Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:4175-4178
15. Napoli R, Biondi B, Guardasole V, D'Anna C, De Sena A, Pirozzi C, Terracciano D, Mazzarella C, Matarazzo M, Saccá L 2008 Enhancement of vascular endothelial function by recombinant human thyrotropin. J Clin Endocrinol Metab 93:1959-1963
16. Deanfield JE, Halcox JP, RabelinkTj 2007 Endothelial function and dysfunction. Testing and clinical relevance. Circulation 115:1285-1295
17. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R 2002 International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39:257-265
18. Reneman RS, Arts T, Hoeks APG 2006 Wall shear stress -an important determinant of endothelial cell function and structure - in the arterial system in vivo, J Vase Res 43:251-269
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St. John Sutton M, Stewart W 2006 American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 7:79-108
20. Settergren M, Böhm F, Ryden L, Peraow J 2008 Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycemia and coronary artery disease. Eur Heart J 29:1753-1760
21. Yasuda S, Miyazaki S, Kanda M, Goto Y, Suzuki M, Harano Y, Nonogi H 2006 Intensive treatment of risk factors in patients with type 2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxide synthase. Eur Heart J 27:1159-1165
22. Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A 2004 The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab 89:740-747
23. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES 2003 Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26:2119-2125
24. Muiesan ML, SalvettiM,Monteduro C, RizzoniD, Zulli R, Corbellini C,Brun C, Agabiti-Rosei E 1999 Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension 33:575-580